48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Circular RNAs (circRNAs) are RNA transcripts that are widespread in the eukaryotic genome. Recent evidence indicates that circRNAs play important roles in tissue development, gene regulation, and carcinogenesis. However, whether circRNAs encode functional proteins remains elusive, although translation of several circRNAs was recently reported.

          Methods

          CircRNA deep sequencing was performed by using 10 pathologically diagnosed glioblastoma samples and their paired adjacent normal brain tissues. Northern blotting, Sanger sequencing, antibody, and liquid chromatograph Tandem Mass Spectrometer were used to confirm the existence of circ-FBXW7 and its encoded protein in in two cell lines. Lentivirus-transfected stable U251 and U373 cells were used to assess the biological functions of the novel protein in vitro and in vivo (five mice per group). Clinical implications of circ-FBXW7 were assessed in 38 pathologically diagnosed glioblastoma samples and their paired periphery normal brain tissues by using quantitative polymerase chain reaction (two-sided log-rank test).

          Results

          Circ-FBXW7 is abundantly expressed in the normal human brain (reads per kilobase per million mapped reads [RPKM] = 9.31). The spanning junction open reading frame in circ-FBXW7 driven by internal ribosome entry site encodes a novel 21-kDa protein, which we termed FBXW7-185aa. Upregulation of FBXW7-185aa in cancer cells inhibited proliferation and cell cycle acceleration, while knockdown of FBXW7-185aa promoted malignant phenotypes in vitro and in vivo. FBXW7-185aa reduced the half-life of c-Myc by antagonizing USP28-induced c-Myc stabilization. Moreover, circ-FBXW7 and FBXW7-185aa levels were reduced in glioblastoma clinical samples compared with their paired tumor-adjacent tissues ( P < .001). Circ-FBXW7 expression positively associated with glioblastoma patient overall survival ( P = .03).

          Conclusions

          Endogenous circRNA encodes a functional protein in human cells, and circ-FBXW7 and FBXW7-185aa have potential prognostic implications in brain cancer.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy

          The National Center for Biotechnology Information (NCBI) Reference Sequence (RefSeq) database is a collection of genomic, transcript and protein sequence records. These records are selected and curated from public sequence archives and represent a significant reduction in redundancy compared to the volume of data archived by the International Nucleotide Sequence Database Collaboration. The database includes over 16 000 organisms, 2.4 × 106 genomic records, 13 × 106 proteins and 2 × 106 RNA records spanning prokaryotes, eukaryotes and viruses (RefSeq release 49, September 2011). The RefSeq database is maintained by a combined approach of automated analyses, collaboration and manual curation to generate an up-to-date representation of the sequence, its features, names and cross-links to related sources of information. We report here on recent growth, the status of curating the human RefSeq data set, more extensive feature annotation and current policy for eukaryotic genome annotation via the NCBI annotation pipeline. More information about the resource is available online (see http://www.ncbi.nlm.nih.gov/RefSeq/).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation.

            FBW7 (F-box and WD repeat domain-containing 7) is the substrate recognition component of an evolutionary conserved SCF (complex of SKP1, CUL1 and F-box protein)-type ubiquitin ligase. SCF(FBW7) degrades several proto-oncogenes that function in cellular growth and division pathways, including MYC, cyclin E, Notch and JUN. FBW7 is also a tumour suppressor, the regulatory network of which is perturbed in many human malignancies. Numerous cancer-associated mutations in FBW7 and its substrates have been identified, and loss of FBW7 function causes chromosomal instability and tumorigenesis. This Review focuses on structural and functional aspects of FBW7 and its role in the development of cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations.

              Chromosomal translocations encode oncogenic fusion proteins that have been proven to be causally involved in tumorigenesis. Our understanding of whether such genomic alterations also affect non-coding RNAs is limited, and their impact on circular RNAs (circRNAs) has not been explored. Here, we show that well-established cancer-associated chromosomal translocations give rise to fusion circRNAs (f-circRNA) that are produced from transcribed exons of distinct genes affected by the translocations. F-circRNAs contribute to cellular transformation, promote cell viability and resistance upon therapy, and have tumor-promoting properties in in vivo models. Our work expands the current knowledge regarding molecular mechanisms involved in cancer onset and progression, with potential diagnostic and therapeutic implications.
                Bookmark

                Author and article information

                Journal
                J Natl Cancer Inst
                J. Natl. Cancer Inst
                jnci
                JNCI Journal of the National Cancer Institute
                Oxford University Press
                0027-8874
                1460-2105
                March 2018
                29 August 2017
                29 August 2017
                : 110
                : 3
                : 304-315
                Affiliations
                [1 ]Department of Neurosurgery, The 1st Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, PR China
                [2 ]Guangdong Provincial Key Laboratory of Pituitary Tumor, Guangzhou, Guangdong Province, PR China
                [3 ]Department of Scientific Research Section, The 1st Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, PR China
                [4 ]Department of Neurosurgery, The University of Texas, MD Anderson Cancer Center, Houston, TX
                [5 ]Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX
                [6 ]Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, PR China
                Author notes

                Authors contributed equally to this work.

                Correspondence to: Nu Zhang, MD, Department of Neurosurgery, The 1st Affiliated Hospital of Sun Yat-Sen University No 58, Zhongshan 2 Road Guangzhou, Guangdong Province 510080 (e-mail: zhangnu2@ 123456mail.sysu.edu.cn ).
                Article
                djx166
                10.1093/jnci/djx166
                6019044
                28903484
                e621924f-a89b-466e-9cc0-16fcbae5bbdc
                © The Author 2017. Published by Oxford University Press.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.

                History
                : 2 January 2017
                : 7 June 2017
                : 25 July 2017
                Page count
                Pages: 12
                Funding
                Funded by: National Natural Science Foundation of China 10.13039/501100001809
                Award ID: 81370072
                Award ID: 81572477
                Funded by: National Cancer Institute 10.13039/100000054
                Award ID: R01CA157933
                Award ID: R01CA172233
                Categories
                Articles

                Oncology & Radiotherapy
                Oncology & Radiotherapy

                Comments

                Comment on this article